PPCB
Propanc Biopharma Inc

1,302
Mkt Cap
$3.06M
Volume
1,022.00
52W High
$11.00
52W Low
$0.1555
PE Ratio
-0.01
PPCB Fundamentals
Price
$0.193
Prev Close
$0.1952
Open
$0.1913
50D MA
$0.3745
Beta
0.00
Avg. Volume
646,918.75
EPS (Annual)
-$14.85
P/B
0.25
Rev/Employee
$0.00
$18.38
Loading...
Loading...

About

Propanc Biopharma, Inc. is a development-stage healthcare company, which engages in the research and development of cancer treatments. The firm focuses on the treatment of pancreatic, ovarian, and colorectal cancer. It offers its product pipeline, including PRP and POP1. The company was founded by James Nathanielsz and Julian Kenyon on October 15, 2007 and is headquartered in Camberwell, Australia.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
2

Frequently Asked Questions

What is Market Cap of Propanc Biopharma Inc?
What is the 52-week high for Propanc Biopharma Inc?
What is the 52-week low for Propanc Biopharma Inc?
What is Propanc Biopharma Inc stock price today?
What was Propanc Biopharma Inc stock price yesterday?
What is the PE ratio of Propanc Biopharma Inc?
What is the Price-to-Book ratio of Propanc Biopharma Inc?
What is the 50-day moving average of Propanc Biopharma Inc?
How many employees does Propanc Biopharma Inc have?

Latest PPCB News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.